Savoia C., Burger D., Nishigaki N., Montezano A. and Touyz RMAngiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med2011; 13: e11.
2.
Savoia C., D’Agostino M., Lauri F. and Volpe M.Angiotensin type 2 receptor in hypertensive cardiovascular disease . Curr Opin Nephrol Hypertens2011; 20: 125-132.
3.
Volpe M., Musumeci B., De Paolis P., Savoia C. and Morganti A.Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease?J Hypertens2003; 21: 1429-1443.
4.
Touyz RM and Schiffrin ELReactive oxygen species in vascular biology: implications in hypertension . Histochem Cell Biol2004; 122: 339-352.
5.
Griendling KK , Sorescu D., Lassegue B. and Ushio-Fukai M.Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol2000; 20: 2175-2183.
6.
Touyz RM, Tabet F. and Schiffrin ELRedox-dependent signalling by angiotensin II and vascular remodelling in hypertension . Clin Exp Pharmacol Physiol2003; 30: 860-866.
7.
Touyz RM and Schiffrin ELSignal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev2000; 52: 639-672.
8.
Jung O., Marklund SL, Geiger H., et al. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res2003; 93: 622-629.
9.
Sarkar S., et al. Influence of cytokines and growth factors in Ang II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am J Physiol Heart Circ Physiol2004; 287: H107-H117.
10.
Azhar M., Schultz Jel J., Grupp I., Dorn GW II, Meneton P., Molin DG, et al. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev2003 ; 14: 391-407.
11.
De Paolis, P., Porcellini A., Gigante B., et al. Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells. J Hypertens1999; 17: 1873-1877.
12.
Cosentino F. , Savoia C., De Paolis P., et al. Angiotensin II type 2 receptor contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens2005; 18: 493-499.
13.
Savoia C., Tabet F., Yao G., Schiffrin EL and Touyz RMNegative regulation of Rho/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens2005; 23: 1037-1045.
14.
Savoia C., Touyz RM, Volpe M. and Schiffrin ELAngiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension2007; 49: 341-346.
15.
Rompe F., Artuc M., Hallberg A., et al Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB. Hypertension2010; 55: 924-931.
16.
Wu L., Iwai M., Nakagami H., et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation2001; 104: 2716-2721.
17.
AbdAlla S., Lother H., Abdel-Tawab AM and Quitterer U.The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem2001; 276: 39721-39726.
18.
Miura S., Matsuo Y., Kiya Y., Karnik SS and Saku K.Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors . Biochem Biophys Res Commun2010 ; 391: 85-90.
19.
Tsutsumi Y. , Matsubara H., Ohkubo N., et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res1998; 83: 1035-1046.
20.
Steckelings UM, Widdop RE, Paulis L. and Unger THThe angiotensin AT2 receptor in left ventricular hypertrophy. J Hypertens2010; 28: S50-S55
21.
Matsumoto T. , Ozono R., Oshima T., et al. Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure . Cardiovasc Res2000; 46: 73-81.
22.
Haywood GA, Gullestad L., Katsuya T., et al. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation1997; 95: 1201-1206.
23.
Altarche-Xifro W., Curato C., Kaschina E., et al. Cardiac c-kit1AT21 cell population is increased in response to ischemic injury and supports cardiomyocyte performance . Stem Cells2009; 27: 2488-2497.
24.
Horiuchi M. , Ayashida W., Kambe T., Yamada T. and Dzau VJAngiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinases phosphatase-1 and induces apoptosis. J Biol Chem1997; 272: 19022-19026.
25.
Gallinat S. , Busche S., Schutze S., Kronke M. and Unger T.AT2 receptor stimulation induces generation of ceramides in PC12W cells. FEBS Lett1999 ; 443: 75-79.